Anika Therapeutics | ANIK - Trade Debtors


Anika Therapeutics reported $21.99M in Trade Debtors for its fiscal quarter ending in March of 2025.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Agenus USD 354K 53K Mar/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Anika Therapeutics USD 21.99M 1.61M Mar/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Insmed USD 140.86M 75.6M Dec/2025
Integra LifeSciences USD 278.85M 16.69M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
J&J USD 17.61B 235M Sep/2025
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Merit Medical Systems USD 223.61M 7.9M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 397M 100M Dec/2025
Smith & Nephew USD 1.48B 85M Dec/2025
Stryker USD 4.04B 396M Dec/2025
Surmodics USD 23.27M 790K Sep/2024
Veracyte USD 44.66M 3.17M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025
Zimmer Biomet Holdings USD 1.7B 106.1M Dec/2025